"All Truth passes through Three Stages: First, it is Ridiculed...
Second, it is Violently Opposed...
Third, it is Accepted as being Self-Evident."
- Arthur Schopenhauer (1778-1860)
By Charly Groenendijk
The Netherlands (ADF) Feb-Sept, 2004 ~ 2009
SUICIDE effect of Cymbalta/Yentreve/Xeristar/Ariclaim (duloxetine) TRAGIC OUTCOME CLINICAL TRIAL ELI LILLY
Cymbalta/Yentreve (duloxetine) side-effects, suicide
Traci Johnson, a 19 year old healthy volunteer with no recent history of depression, committed suicide by hanging while
testing Lilly's drug, Cymbalta (duloxetine), at Lilly's Laboratory for Clinical Research. Cymbalta is most closely related to Wyeth's SSNRI Effexor (venlafaxine), click here to view side-effects.
In previous Cymbalta trials, four other individuals committed suicide.
The FDA has approved Eli Lilly's new antidepression, stress urinary incontinence & diabetic nerve pain medication, Cymbalta (Yentreve, Xeristar, Duloxetine),
regardless serious risk of liver toxicity, risk of suicide & self-harm and risk of violent behavior in
children and adults.
Cymbalta (duloxetine) is most closely related to the SSNRI Effexor (venlafaxine), Wyeth's antidepressant.
View side-effects of Effexor (venlafaxine) -as reported by physicians- to be expected with Cymbalta (duloxetine).
Go to: CYMBALTA/YENTREVE/XERISTAR (duloxetine) SEVERE SIDE-EFFECTS EXPECTEDTraci Johnson
(see picture), a 19-year-old woman who was participating in a clinical trial for Lilly's new drug Cymbalta (duloxetine)
commits suicide on the 7th of February 2004, by hanging herself(-tying a scarf to a bathroom shower rod-) in
Lilly Laboratory for Clinical Research.
Read more,
(2),
(3),
(4),
(5),
(6),
(7),
(8),
(9),
(10)
In previous trials of Cymbalta (duloxetine) there were
four other individuals who had committed suicide.
Traci Johnson joined the trial in early January. She initially
had been given duloxetine but, at the time of her death, had been taking a placebo for four days.
Another SSNRI, Effexor (Efexor, venlafaxine), which is most closely related to
the Lilly SSNRI Cymbalta, has listed side-effects such as: akathisia & mania, delirium, hallucinations and paranoid delusion,
following use and/or discontinuation of the drug.
What could have happened to Traci Johnson? With the latest knowledge regarding severe withdrawal reactions that are repeatedly being
observed in SSRI/SSNRI discontinuation, as reported by physicians in Effexor, it is not difficult to understand that Traci Johnson
suffered from severe withdrawal reactions after discontinuation of Cymbalta.
WHY HANGING? Why such a violent method? Cymbalta is a drug that similar to Eli Lilly's Prozac (Sarafem, fluoxetine) acts on serotonin
and next to it on nor-epinephrine in the brain. It is not a coincidence that violent methods of suicide have been
associated with the serotonin acting drug Prozac (Sarafem, fluoxetine) before.
See: Fluoxetine and Violent Death in Maryland: violent methods in fluoxetine suicides.
Clearly, Cymbalta (Yentreve, duloxetine) is another very powerful mind-altering and potentially lethal new SSNRI antidepressant, stress urinary incontinence & diabetic nerve pain medication to
protect yourself from and especially your children.
Sept 4, 2004: Attorney questions FDA probe of Lilly:
Family of Cymbalta/Yentreve trial suicide victim [Traci Johnson] says it wasn't consulted; details of investigation still unreleased.
The information the FDA gathered to investigate Johnson's suicide appears to have come primarily from Lilly.
"It's difficult to believe . . . the information provided to the FDA was objective and not self-serving," he [attorney] said...
Read more.
SIDE-EFFECTS OF EFFEXOR TO BE EXPECTED WITH CYMBALTA/YENTREVE (DULOXETINE)
THE REAL SIDE-EFFECTS THAT YOU WON'T SEE ON YOUR PRESCRIPTION LEAFLET:
-as reported by medical physicians-
Traci Johnson
(see picture), a 19-year-old woman who was participating in a clinical trial for Lilly's new drug Cymbalta (duloxetine)
commits suicide on the 7th of February 2004, by hanging herself (-tying a scarf to a bathroom shower rod-) in
Lilly Laboratory for Clinical Research.